Icon Plc (NASDAQ: ICLR) is a contract research organization (“CRO”). In the Q3 2024 letter, I highlighted our investment in Medpace (MEDP) another CRO that directly competes with Icon.

DUBLIN 18, Ireland (AP) — Icon PLC (ICLR) on Wednesday reported first-quarter earnings of $154.2 million. The Dublin 18, Ireland-based company said it had profit of $1.90 per share. Earnings… ...

Icon PLC (ICLR) delivered earnings and revenue surprises of 0.29% and 0.29%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Icon PLC (ICLR) delivered earnings and revenue surprises of 1.63% and 0.56%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

There are two ways to make a background transparent in Photoshop: using the "Remove Background" quick action or manually by using selection tools.

ICON PLC Investors: Please contact the Portnoy Law Firm to recover your losses. April 11, 2025 Deadline to file Lead Plaintiff Motion ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will ...

ICON to partner with US government agency to test COVID vaccine candidates Contract research firm ICON Plc said on Wednesday it is partnering with the U.S. government for a clinical trial to test ...

A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical ...

ICON PLC Investors: Please contact the Portnoy Law Firm to recover your losses. April 11, 2025 Deadline to file Lead Plaintiff Motion News provided by Portnoy Law Apr 07, 2025, 4:21 PM ET ...